// App-Quantinova.ai

e15616 : Clinicopathologic and prognostic features of hepatocellular carcinoma (HCC) due to metabolic syndrome (MS) compared to chronic liver disease (CLD) and cryptogenic causes (CC).

Researchers

Presenter

  • Matthew L Chase

Principal Investigators

  • Nikroo Hashemi

  • Stephanie Reyes

  • Kathleen E Corey

  • Joseph Misdraji

  • Andrew X. Zhu

  • Lipika Goyal

Medical Centers

  • Brigham and Women's Hospital, Brookline, MA

  • Gastroenterology and Hepatology, Brigham and Womens Hospital, Boston, MA

  • Dana-Farber Cancer Institute, Boston, MA

  • MGH Gastrointerstinal Unit, Harvard Medical School, Boston, MA

  • Department of Pathology, Massachusetts General Hospital, Boston, MA

  • Massachusetts General Hospital Cancer Center, Boston, MA

  • MGH Cancer Center, Brookline, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Liver cancer

  • Chronic Liver Disease

  • Autoimmune hepatitis

  • Metabolic syndrome

  • Hemochromatosis

  • Alcohol Dependence

  • Hypertension

  • Solid malignancies

  • Diabetes

  • Obesity

  • Nonalcoholic fatty liver disease

Biomarkers

  • Alpha-fetoprotein

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved